Addition of Yttrium-90 ibritumomab tiuxetan to BEAM conditioning prior to autografting does not improve outcome of chemorefractory patients with aggressive B-cell NHL

Category Primary study
JournalHaematologica
Year 2009
This article has no abstract
Epistemonikos ID: a95f79cbabbd7cc62cf81c8fd6ccd6d71b04a7eb
First added on: Feb 28, 2025